MLKMF Waldencast plc
Perfumes, Cosmetics & Other Toilet Preparations · OTC · SEC CIK 1840199
Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY-0.7%
TTM net income YoY-441.3%
TTM EPS YoY-415.4%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin67.3%
Operating margin-80.0%
Net margin-84.4%
FCF margin-6.0%
EBITDA margin-78.8%
Returns
ROE-40.9%
ROA-26.7%
ROIC (approx.)-24.9%
Asset turnover0.32x
Leverage & solvency
Liabilities / assets33.0%
Debt / equity0.30x
Current ratio1.70x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.06x
Accruals ratio-25.2%
Payout ratio—
Capex / revenue1.3%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2022Q1*2022-03-31 | 2021Q4*2021-12-31 | 2021Q32021-09-30 | 2021Q22021-06-30 | 2021Q12021-03-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | — | — | — | — | — |
| Operating income | -$4.00M | -$8.17M | -$645,123 | -$201,567 | -$117,515 |
| Net income | $3.02M | -$19.45M | $7.76M | -$1.55M | -$1.18M |
| EPS (basic) | — | — | 0.18 | 0.00 | 0.00 |
| EPS (diluted) | — | — | 0.18 | 0.00 | -0.13 |
| Weighted avg. shares (diluted) | — | — | 34.50M | 29.84M | 9.34M |
| Balance sheet | |||||
| Cash & equivalents | $1.09M | $13.44M | $335,058 | $851,860 | $1.45M |
| Receivables | — | $18.74M | — | — | — |
| Inventory | — | $21.61M | — | — | — |
| Current assets | $1.25M | $59.04M | $554,383 | $1.15M | $1.98M |
| PP&E, net | — | $1.20M | — | — | — |
| Goodwill | — | $44.49M | — | — | — |
| Intangibles | — | $79.57M | — | — | — |
| Total assets | $346.31M | $184.59M | $345.70M | $346.30M | $346.98M |
| Current liabilities | $1.77M | $40.80M | $131,739 | $105,746 | $592,749 |
| Short-term debt | — | $15.44M | — | — | — |
| Long-term debt | — | $103.42M | — | — | — |
| Total debt | — | $118.86M | — | — | — |
| Total liabilities | $53.09M | $145.35M | $36.06M | $44.42M | $43.55M |
| Shareholders' equity | -$51.79M | $39.24M | -$35.36M | -$43.12M | -$41.57M |
| Net debt | — | $105.42M | — | — | — |
| Shares outstanding | — | 8.00M | — | — | — |
| Cash flow statement | |||||
| Operating cash flow | -$414,788 | $352,628 | -$516,801 | -$597,827 | -$53,682 |
| Investing cash flow | — | $0 | $0 | $0 | -$345.00M |
| Financing cash flow | — | $816,081 | $0 | $0 | $346.50M |
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.